To study the telomeras revers transcriptas (TERT) mutation and the p53 pathway in T1 urinary bladder cancer (UBC).
This prospectively performed population-based study included all patients in the Southeast Healthcare Region in Sweden with T1 UBC registered in the period 1992-2001, inclusively.